市场调查报告书
商品编码
1396537
临床试验供应和物流市场 - 按服务类型(物流和配送)、阶段(第一阶段、第二阶段)、治疗领域(肿瘤学、眼科)、最终用途、全球预测,2023 - 2032 年Clinical Trial Supply & Logistics Market - By Service Type (Logistics & Distribution), Phase (Phase I, Phase II), Therapeutic Area (Oncology, Ophthalmology), End-use, Global Forecast, 2023 - 2032 |
在全球生物製药产业不断扩大的推动下,临床试验供应和物流市场规模预计从 2023 年到 2032 年将以 7.9% 的CAGR扩大。药物开发(特别是生物製剂和特种药物)的持续创新正在扩大生物製药领域对专业供应和物流服务的需求。生物製药产品的复杂性进一步需要客製化的储存、处理和运输解决方案。
随着人们越来越关注透过复杂的製造流程推进疗法,一些製药公司、合约研究组织(CRO) 和物流提供者正在建立合作伙伴关係,以提高临床试验供应链的效率和可靠性,进一步推动产业前景。 2023 年 6 月,药品温控提供者 SkyCell 与 Marken 携手,为临床试验药品提供升级的运送选项。
临床试验供应和物流行业分为服务类型、阶段、治疗领域、最终用途和区域。
就服务类型而言,预计2023-2032年药品製造领域的市占率复合CAGR为5.7%。製药公司不断努力为新药开发进行广泛的临床试验,这增加了对高效、可靠的供应链解决方案的需求。人们日益关注维持监管合规性和最大限度地降低成本,以及确保研究药物从生产设施及时安全地交付到临床试验场所的专业服务的可用性不断增加,预计将推动该细分市场的成长。
根据最终用途,到 2032 年,医疗器材公司领域的临床试验供应和物流市场预计将以 6.3% 的成长率成长。随着多家医疗器材公司参与广泛的临床试验,将创新产品推向市场,需求高效率、专业的供应链解决方案的需求量显着上升。此外,人们越来越倾向于客製化服务,以确保及时、安全地将研究医疗设备交付到临床试验地点,预计将推动该细分市场的成长。
从地区来看,欧洲临床试验供应和物流行业在 2022 年占据了相当大的收入份额,在蓬勃发展的製药和生物技术行业的推动下,2023 年至 2032 年期间将呈现 7.8% 的增长率。由于拥有完善的基础设施、监管架构和经验丰富的临床研究环境,欧洲已成为全球临床试验的重要中心,进一步增加了对专业供应链和物流服务的需求。
一些产业参与者也为医疗保健组织提供更简化的解决方案,以解决新药开发不断增加所带来的物流问题。例如,2023年10月,UPS Healthcare在英国、法国、义大利、德国和西班牙推出了UPS Pickup Point站点,为健康实验室客户提供新的逆向物流服务。
Clinical Trial Supply & Logistics Market size is projected to expand at 7.9% CAGR from 2023-2032 driven by the expanding biopharmaceutical sector worldwide. The continuous innovations in drug development, particularly biologics and specialty drugs, is amplifying the demand for specialized supply and logistics services across the biopharma domain. The intricate nature of biopharmaceutical products is further necessitating tailored solutions for storage, handling, and transportation.
With the surging focus on advancing therapies with complex manufacturing processes, several pharmaceutical companies, contract research organizations (CROs), and logistics providers are entering partnerships to enhance the efficiency and reliability of clinical trial supply chains, further propelling the industry outlook. In June 2023, pharma temperature-controlled provider SkyCell joined hands with Marken to deliver upgraded transportation options for clinical trials pharmaceutical goods.
The clinical trial supply & logistics industry is segmented into service type, phase, therapeutic area, end-use, and region.
In terms of service type, the market share from the drug manufacturing segment is anticipated to depict 5.7% CAGR from 2023-2032. The ongoing efforts by pharmaceutical companies to conduct extensive clinical trials for the development of new drugs is surging the demand for efficient and reliable supply chain solutions. The rising focus on maintaining regulatory compliance and minimizing costs along with the increasing availability of specialized services for ensuring timely and secure delivery of investigational drugs from manufacturing facilities to clinical trial sites is expected to propel segment growth.
Based on end-use, the clinical trial supply & logistics market from the medical device companies segment is expected to depict 6.3% growth rate through 2032. With several medical device companies engaging in extensive clinical trials to bring innovative products to the market, the demand for efficient and specialized supply chain solutions is significantly rising. Additionally, the increasing preference for tailored services to ensure the timely and secure delivery of investigational medical devices to clinical trial sites is anticipated to fuel the segment growth.
Regionally, the Europe clinical trial supply and logistics industry held sizable revenue share in 2022 and is set to exhibit 7.8% growth rate between 2023 and 2032 propelled by the thriving pharmaceutical and biotechnology sectors. Europe has emerged as a prominent hub for global clinical trials owing to the presence of an established infrastructure, regulatory frameworks, and experienced clinical research landscape, further surging the demand for specialized supply chain and logistics services.
Several industry participants are also offering more streamlined solutions to healthcare organizations to address the logistic issues propelled by the increased development of new medicines. For instance, in October 2023, UPS Healthcare launched UPS Pickup Point sites in the U.K., France, Italy, Germany, and Spain to provide a new reverse logistics service for health laboratory clients.